Abstract
A series of novel indole derivatives were synthesized as potent inhibitors for the vascular endothelial growth factor receptor 2 (VEGFR-2) tyrosine kinase. Among those, compound 10b demonstrated the highest growth inhibition rate of 66.7% against the VEGFR-2 tyrosine kinase at 10 μM which indicates that indole-benzothiazole might be the favorable structure. The binding mode of compound 10b with VEGFR-2 tyrosine kinase was evaluated by molecular docking.
References
Herdman, C.A., Devkota, L., Lin, C.M., Niu, H., Strecker, T.E., Lopez, R., Li, L., George, C.S., Tanpure, R.P. and Hamel, E., Bioorgan. Med. Chem., 2015, vol. 23, p. 7497. doi 10.1016/j.bmc.2015.10.012
Siemann, D.W., Chaplin, D.J., and Horsman, M.R., Cancer, 2005, vol. 104, p. 216. doi 10.1002/cncr.21120
Bold, G., Schnell, C., Furet, P., McSheehy, P., Brüggen, J., Jürgen, M., Manley, P.W., Drueckes, P., Burglin, M., and Dürler, U.J., Med. Chem., 2016, vol. 59, p. 132. doi 10.1021/acs.jmedchem.5b01582
Kang, C.M., Liu, D.Q., Wang, X.Y., Yu, R.L., and Lv, Y.T., J. Mol. Graph. Model., 2015, vol. 59, p. 130. doi 10.1016/j.jmgm.2015.04.011
La, L., Ps, S., and Wg, S.-S., Cell, 1991, vol. 64, p. 327. doi 10.1016/0092-8674(91)90642-C
Parangi, S., O'Reilly, M., Christofori, G., Holmgren, L., Grosfeld, J., Folkman, J., and Hanahan, D., Proc. Natl. Acad. Sci., 1996, vol. 93, p. 2002.
Folkman, J., Ann. Surg., 1972, vol. 175, p. 409.
Hahn, O. and Stadler, W., Curr. Opin. Oncol., 2006, vol. 18, p. 615. doi 10.1097/01.cco.0000245316.82391.52
Druker, B.J., Tamura, S., Buchdunger, E., Ohno, S., Segal, G.M., Fanning, S., Zimmermann, J., and Lydon, N.B., Nat. Med., 1996, vol. 2, p. 561. doi 10.1038/nm0596-561
Barker, A.J., Gibson, K.H., Grundy, W., Godfrey, A.A., Barlow, J.J., Healy, M P., Woodburn, J.R., Ashton, S.E., Curry, B.J., and Scarlett, L., Bioorg. Med. Chem. Lett., 2001, vol. 11, p. 1911. doi 10.1002/chin.200146147
Feng, S., Yuan, T., Chen-Yu, T., Fei, Z., and Xin-Yan, W., J. Org. Chem., 2015, vol. 80, p. 8122. doi 10.1021/acs.joc.5b01223
El-Sawy, E.R., Abo-Salem, H.M., Mahmoud, K., Zarie, E.S., El-Metwally, A.M., and Mandour, A. H., Int. J. Pharm. Pharm. Sci., 2015, vol. 7, p. 377.
El-Sawy, E., Mandour, A., Yahya, S., Abo-Salem, H., and Ebaid, M., Egypt. Pharm. J., 2015, vol. 14, p. 15. doi 10.4103/1687-4315.154695
Madadi, N.R., Penthala, N.R., Janganati, V., and Crooks, P.A., Bioorg. Med. Chem. Lett., 2014, vol. 24, p. 601. doi 10.1016/j.bmcl.2013.12.013
Papaetis, D.G.S. and Syrigos, K.N., Biodrugs, 2009, vol. 23, p. 377. doi 10.2165/11318860-000000000-00000
Sekwon Jang, M.D., Chaoyi Zheng, M.S., Tsai, H.T., Fu, A.Z., Barac, A., Atkins, M.B., Freedman, A.N., Lori Minasian, M.D., and Potosky, A.L., Cancer, 2016, vol. 122, p. 124. doi 10.1002/cncr.29728
Jiang, F. and Kang, C., Chemistry, 2015, vol. 78, p. 378. doi 10.14159/j.cnki.0441-3776.2015.04.017
Jing, X., Zhu, Q., Xu, F., Ren, X., Li, D., and Yan, C., Cheminform, 2006, vol. 36, p. 2597. doi 10.1002/chin.200707098
Siegart, W.R. and Day, A.R., J. Am. Chem. Soc., 1957, vol. 79, p. 4391. doi 10.1021/ja01573a041
Melzer, M.S., J. Org. Chem., 1962, vol. 27, p. 496. doi 10.1021/jo01049a038
Süs, O. and Möller, K., Eur. J. Org. Chem., 1955, vol. 593, p. 91. doi 10.1002/jlac.19555930202
Baiocchi, L. and Giannangeli, M., J. Heterocyclic Chem., 1988, vol. 25, p. 1905. doi 10.1002/jhet.5570250654
Venkatesh, P. and Pandeya, S.N., Int. J. Chemtech. Res., 2009, vol. 1, p. 1354.
Henry, D.W., and Leete, E., J. Am. Chem. Soc., 1957, vol. 79, p.5254. doi 10.1021/ja01576a051
Borgne, M.L., Marchand, P., Duflos, M., Delevoye-Seiller, B., Piessard-Robert, S., Baut, G.L., Hartmann, R.W., and Palzer, M., Archiv. Der. Pharmazie. 1997, vol. 330, p. 141. doi 10.1002/chin.199742155
Li, Y. and Tan, R., Liaoning. Chem. Ind., 1999, vol. 28, p. 97.
Skolnik, H., Miller, J.G., and Day, A.R., J. Am. Chem. Soc., 2002, vol. 65, p. 1858. doi 10.1021/ja01250a020
Shen, X.A., Mod. Chem. Ind., 2008, vol. 28, p. 43. doi 10.16606/j.cnki.issn0253-4320.2008.06.002
Ge, Y., Wu, Y., Xue, Z., and Zhou, M., Chem. Ind. Times., 2004, vol. 18, p. 24. doi 10.16597/j.cnki.issn.1002-154x.2004.07.008
Lee, K.Y., Lee, H.S., and Kim, J.N., Cheminform, 2007, vol. 28, p. 333. doi 10.1002/chin.200728113
Ferro, S., Grazia, S.D., Luca, L.D., Barreca, M.L., Debyser, Z., and Chimirri, A., Heterocycles, 2009, vol. 78, p. 947. doi 10.3987/com-08-11573
Trott, O. and Olson, A.J., J. Comput. Chem., 2010, vol. 31, p. 455. doi 10.1002/jcc.21334
Pettersen, E.F., Goddard, T.D., Huang, C.C., Couch, G.S., Greenblatt, D.M., Meng, E.C., and Ferrin, T.E., J. Comput. Chem., 2004, vol. 25, p. 1605. doi 10.1002/jcc.20084
Author information
Authors and Affiliations
Corresponding author
Additional information
The text was submitted by the authors in English.
Rights and permissions
About this article
Cite this article
Zhang, C., Xu, D., Wang, J. et al. Efficient Synthesis and Biological Activity of Novel Indole Derivatives as VEGFR-2 Tyrosine Kinase Inhibitors. Russ J Gen Chem 87, 3006–3016 (2017). https://doi.org/10.1134/S1070363217120465
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S1070363217120465